电针联合温针治疗足跟痛的疗效与安全性:随机对照试验研究方案
本研究为在香港开展的前瞻性、开放标签、平行组随机对照试验,拟招募80例50-80岁、足跟痛且第一步痛VAS≥50 mm的患者,按1:1随机分入电针联合温针组或等待对照组。治疗组4周内接受6次治疗,主要结局为基线至第4周第一步痛VAS均值变化,采用意向性分析。
要点
- 电针联合温针组4周内接受6次治疗,对照组研究期间不接受治疗。
- 主要结局为基线至第4周第一步痛VAS均值变化,次要结局包括第2周VAS变化及FFI评分变化等。
- 研究结果将为电针联合温针作为足跟痛替代疗法提供疗效与安全性证据。
核心结论
- 本研究旨在评估电针联合温针治疗足跟痛的临床疗效与安全性,结果将为该疗法作为替代治疗提供证据,并确定该方案能否缓解老年足跟痛患者的疼痛和改善足功能。
研究设计与样本
- 前瞻性、开放标签、平行组随机对照试验,计划在香港招募80例50-80岁、足跟痛且第一步痛VAS≥50 mm(100 mm量表)的患者,按1:1随机分入电针联合温针组或等待对照组,采用意向性分析。
主要发现
- 治疗组在4周内接受6次治疗,对照组在研究期间不接受治疗。
- 主要结局为基线至第4周第一步痛VAS均值变化;次要结局包括基线至第2周第一步痛VAS均值变化、基线至第2周和第4周FFI各分量表及总分均值变化、第4周患者自报改善程度。
- 治疗组另安排第8周随访,评估第一步痛VAS和FFI;研究全程记录不良事件以评估安全性。
关键数值与推荐
- 纳入标准:年龄50-80岁,有足跟痛且第一步痛在100 mm视觉模拟量表(VAS)上等于或超过50 mm。
- 主要结局指标:基线至第4周第一步痛VAS评分均值变化。
- 次要结局指标:基线至第2周第一步痛VAS均值变化;基线至第2周和第4周足功能指数(FFI)分量表及总分均值变化;第4周患者自报改善水平。
- 治疗组在第8周追加第一步痛VAS和FFI随访评估。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heel pain is a common foot disorder that causes pain and functional limitations. The prevalence of disabling foot pain will increase as the population ages. Previous studies have reported the positive therapeutic effects of electroacupuncture, warm needling, or the combination of both for heel pain but with limitations in the study methodologies. The current study is a rigorously designed randomized controlled trial that aims to evaluate the clinical efficacy and safety of electroacupuncture plus warm needling therapy in patients with heel pain. METHODS/DESIGN: The study protocol describes a prospective, open-label, parallel-group, randomized controlled trial to be conducted in Hong Kong. Eighty patients aged 50-80 years who have reported heel pain and first-step pain equal to or exceeding 50 mm on the 100-mm visual analog scale (VAS) will be recruited. They will be randomly assigned (1:1 ratio) to the electroacupuncture plus warm needling therapy (i.e., treatment) group or the waitlist (i.e., control) group. The treatment group will undergo six treatment sessions in 4 weeks. The control group will receive no treatment during the study period. The primary outcome measure is a mean change in the first-step pain VAS score from the baseline to week 4. Secondary outcome measures include a mean change in first-step pain VAS score from the baseline to week 2, a mean change in Foot Function Index (FFI) subscale scores and the total score from the baseline to week 2 and week 4, and patients' self-reported level of improvement at week 4. Additional week 8 follow-up assessments with first-step pain VAS and FFI measurements will be arranged for the treatment group. Any adverse events will be recorded throughout the study to evaluate safety. An intention-to-treat approach will be used to analyze the study results. DISCUSSION: This study will provide evidence on the efficacy and safety of electroacupuncture plus warm needling therapy as an alternative treatment method for heel pain. The findings will determine whether the treatment protocol is efficacious in relieving pain and improving foot function among older adults with heel pain. The study will also provide information for subsequent large-scale randomized controlled trials in the future. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR1800014906 . Registered on 12 February 2018.
引用
- Ho LF, Guo Y, Ching JY, et al. Efficacy and safety of electroacupuncture plus warm needling therapy for heel pain: study protocol for a randomized controlled trial. Trials. 2019. PMID: 31391104. doi:10.1186/s13063-019-3572-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。